The largest database of trusted experimental protocols

E coli shuffle strain

Manufactured by New England Biolabs
Sourced in United States, United Kingdom

The E. coli SHuffle strain is a genetically engineered Escherichia coli cell line designed for the expression and production of recombinant proteins. The strain is optimized for the formation of disulfide bonds, which are important for the proper folding and stability of many proteins.

Automatically generated - may contain errors

2 protocols using e coli shuffle strain

1

Engineered E. coli Strains for PUFA Biosynthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
E. coli Top10 was purchased from Invitrogen Biotechnology Co. (Grand Island, NY, USA). E. coli fabD mutant (ΔfabD) was obtained from the Coli Genetic Stock Center from the Yale University (New Haven, CO, USA). E. coli ∆fadD strain was provided by Dr. Pamela Silver, Harvard Medical School (Boston, MA, USA) [21 (link)]. E. coli SHuffle strain was acquired from New England BioLabs (Ipswich, MA, USA) (Table S1). The pCDFDuet-1 vector with the ORF-B of the PUFA synthase from Thraustochytrium sp. 26185 was obtained from our previous research [14 (link)]. Expression vectors, pBAD and pET28a, were purchased from Invitrogen Co. (Carlsbad, CA, USA) (Table S2). DNA purification kit was acquired from Bio Basic Inc. (York, ON, Canada). Q5 polymerase, restriction enzymes and dNTP were purchased from New England Biolabs (NEB) (Ipswich, MA, USA). HP Taq DNA polymerase was purchased from Bio Basic Inc. T4 ligase was acquired from Thermo Fisher Scientific. EcoRI, HindIII, and BglII restriction enzymes were purchased from NEB. Primers for MAT PCR amplifications and site-directed mutagenesis (Table S3) were synthesized by Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
2

Recombinant Protein Production in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pCold-NPGM-Gly plasmid was transformed into E. coli BL21 strain (GE Healthcare, Little Chalfont, UK) or E. coli SHuffle strain (New England Biolabs, Ipswich, MA, USA). The transformants were selected on LB agar plates containing 50 μg/ml of ampicillin and grown at 37 °C overnight. The colonies were then grown in LB medium containing ampicillin at 37 °C overnight. An aliquot of the pre-culture solution was diluted with 200 ml of fresh LB medium and incubated at 37 °C. When the cells reached an optical density (OD)600 of 0.5, the culture was refrigerated at 15 °C for 30 min. The culture solution was added with isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final concentration of 0.1 mM and continued with shaking at 15 °C for 24 h. Cells were collected by centrifugation and frozen at −80 °C until further use.
The expression of the target protein in soluble and in insoluble fractions was confirmed by SDS–PAGE. An aliquot of the cell pellet was lysed with BugBuster Protein Extraction Reagent (Novagen, Madison, WI, USA) and separated by centrifugation. Each sample was dissolved in SDS sample buffer and subjected to 15% SDS–PAGE. The gels were stained with 2D-SILVER STAIN II (Cosmobio, Tokyo, Japan).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!